Alaunos Therapeutics Inc (TCRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2007 | 12-2006 | 09-2006 | 06-2006 | 03-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 52,701 | 26,856 | 32,962 | 32,577 | 1,079 |
| Marketable Securities | N/A | 1,555 | 1,536 | 4,553 | 4,500 |
| TOTAL | $53,275 | $28,873 | $34,813 | $37,349 | $5,875 |
| Non-Current Assets | |||||
| PPE Net | 602 | 451 | 295 | 295 | 302 |
| Other Non-Current Assets | 309 | 188 | 187 | 132 | 131 |
| TOTAL | $910 | $639 | $482 | $427 | $433 |
| Total Assets | $54,185 | $29,512 | $35,295 | $37,776 | $6,308 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 956 | 776 | 1,144 | 627 | 545 |
| Accrued Expenses | 2,402 | 2,162 | 2,137 | 2,013 | 1,443 |
| TOTAL | $3,358 | $2,938 | $3,281 | $2,640 | $1,988 |
| Non-Current Liabilities | |||||
| TOTAL | $41 | $41 | $40 | $37 | $36 |
| Total Liabilities | $3,398 | $2,979 | $3,321 | $2,677 | $2,024 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 141 | 102 | 102 | 102 | 102 |
| Common Shares | 21 | 15 | 15 | 15 | 7 |
| Retained earnings | -38,262 | -33,221 | -27,403 | -23,948 | -18,583 |
| TOTAL | $50,787 | $26,533 | $31,974 | $35,098 | $4,284 |
| Total Liabilities And Equity | $54,185 | $29,512 | $35,295 | $37,776 | $6,308 |